Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Given Average Recommendation of “Buy” by Analysts
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS – Get Free Report) has earned an average rating of “Buy” from the seven analysts that are covering the stock, MarketBeat reports. One equities research analyst has rated the stock with a hold rating, five have issued a buy rating and one has given a strong buy rating to the company. […]
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS – Get Free Report) has earned an average rating of “Buy” from the seven analysts that are covering the stock, MarketBeat reports. One equities research analyst has rated the stock with a hold rating, five have issued a buy rating and one has given a strong buy rating to the company. […]
